276 related articles for article (PubMed ID: 19234517)
21. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
[TBL] [Abstract][Full Text] [Related]
22. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
23. Benign clear cell "sugar" tumor of the lung in a patient with Birt-Hogg-Dubé syndrome: a case report.
Gunji-Niitsu Y; Kumasaka T; Kitamura S; Hoshika Y; Hayashi T; Tokuda H; Morita R; Kobayashi E; Mitani K; Kikkawa M; Takahashi K; Seyama K
BMC Med Genet; 2016 Nov; 17(1):85. PubMed ID: 27871249
[TBL] [Abstract][Full Text] [Related]
24. Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt-Hogg-Dubé patients.
van Steensel MA; Verstraeten VL; Frank J; Kelleners-Smeets NW; Poblete-Gutiérrez P; Marcus-Soekarman D; Bladergroen RS; Steijlen PM; van Geel M
J Invest Dermatol; 2007 Mar; 127(3):588-93. PubMed ID: 17124507
[TBL] [Abstract][Full Text] [Related]
25. High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors.
Vocke CD; Yang Y; Pavlovich CP; Schmidt LS; Nickerson ML; Torres-Cabala CA; Merino MJ; Walther MM; Zbar B; Linehan WM
J Natl Cancer Inst; 2005 Jun; 97(12):931-5. PubMed ID: 15956655
[TBL] [Abstract][Full Text] [Related]
26. The Role of Heat Shock Protein-90 in the Pathogenesis of Birt-Hogg-Dubé and Tuberous Sclerosis Complex Syndromes.
Woodford MR; Backe SJ; Sager RA; Bourboulia D; Bratslavsky G; Mollapour M
Urol Oncol; 2021 Jun; 39(6):322-326. PubMed ID: 32327294
[TBL] [Abstract][Full Text] [Related]
27. Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia.
Toro JR; Glenn G; Duray P; Darling T; Weirich G; Zbar B; Linehan M; Turner ML
Arch Dermatol; 1999 Oct; 135(10):1195-202. PubMed ID: 10522666
[TBL] [Abstract][Full Text] [Related]
28. New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome.
Kennedy JC; Khabibullin D; Boku Y; Shi W; Henske EP
Semin Respir Crit Care Med; 2020 Apr; 41(2):247-255. PubMed ID: 32279295
[TBL] [Abstract][Full Text] [Related]
29. Pathology of Birt-Hogg-Dubé syndrome: A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review.
Furuya M; Nakatani Y
Pathol Int; 2019 Jan; 69(1):1-12. PubMed ID: 30632664
[TBL] [Abstract][Full Text] [Related]
30. [Multiple spontaneous pneumothoraces revealing Birt-Hogg-Dube syndrome].
Van Denhove A; Guillot-Pouget I; Giraud S; Isaac S; Freymond N; Calender A; Pacheco Y; Devouassoux G
Rev Mal Respir; 2011 Mar; 28(3):355-9. PubMed ID: 21482341
[TBL] [Abstract][Full Text] [Related]
31. Regulation of folliculin (the BHD gene product) phosphorylation by Tsc2-mTOR pathway.
Piao X; Kobayashi T; Wang L; Shiono M; Takagi Y; Sun G; Abe M; Hagiwara Y; Zhang D; Okimoto K; Kouchi M; Matsumoto I; Hino O
Biochem Biophys Res Commun; 2009 Nov; 389(1):16-21. PubMed ID: 19695222
[TBL] [Abstract][Full Text] [Related]
32. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
[TBL] [Abstract][Full Text] [Related]
33. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.
Dong L; Gao M; Hao WJ; Zheng XQ; Li YG; Li XL; Yu Y
Medicine (Baltimore); 2016 May; 95(22):e3695. PubMed ID: 27258496
[TBL] [Abstract][Full Text] [Related]
34. Birt-Hogg-Dubé syndrome with a renal angiomyolipoma: further evidence of a relationship between Birt-Hogg-Dubé syndrome and tuberous sclerosis complex.
Byrne M; Mallipeddi R; Pichert G; Whittaker S
Australas J Dermatol; 2012 May; 53(2):151-4. PubMed ID: 22571569
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.
da Silva NF; Gentle D; Hesson LB; Morton DG; Latif F; Maher ER
J Med Genet; 2003 Nov; 40(11):820-4. PubMed ID: 14627671
[TBL] [Abstract][Full Text] [Related]
36. [Birt-Hogg-Dubé syndrome].
Koga S; Furuya M; Nakatani Y
Nihon Rinsho; 2010 Feb; 68(2):361-9. PubMed ID: 20158110
[TBL] [Abstract][Full Text] [Related]
37. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
[TBL] [Abstract][Full Text] [Related]
38. Syndrome of Birt-Hogg-Dubé, a histopathological pitfall with similarities to tuberous sclerosis: a report of three cases.
Spring P; Fellmann F; Giraud S; Clayton H; Hohl D
Am J Dermatopathol; 2013 Apr; 35(2):241-5. PubMed ID: 23542717
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic targeting the loss of the birt-hogg-dube suppressor gene.
Lu X; Wei W; Fenton J; Nahorski MS; Rabai E; Reiman A; Seabra L; Nagy Z; Latif F; Maher ER
Mol Cancer Ther; 2011 Jan; 10(1):80-9. PubMed ID: 21220493
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.
Iribe Y; Kuroda N; Nagashima Y; Yao M; Tanaka R; Gotoda H; Kawakami F; Imamura Y; Nakamura Y; Ando M; Araki A; Matsushima J; Nakatani Y; Furuya M
Pathol Int; 2015 Mar; 65(3):126-32. PubMed ID: 25597876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]